Cristiano, Lynda et al "Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry (P02.127)." Neurology 80.7 Supplement (2013): P02.127. Web. 25 Oct. 2021.